Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19

被引：94

作者：

Keller, Marla J. ^{[1
,2
]}

Kitsis, Elizabeth A. ^{[2
,3
]}

Arora, Shitij ^{[2
,4
]}

Chen, Jen-Ting ^{[2
,5
]}

Agarwal, Shivani ^{[2
,6
]}

Ross, Michael J. ^{[2
,7
]}

Tomer, Yaron ^{[2
,6
]}

Southern, William ^{[2
,4
]}

机构：

[1] Montefiore Med Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA

[2] Albert Einstein Coll Med, Bronx, NY 10467 USA

[3] Montefiore Med Ctr, Dept Med, Div Rheumatol, Bronx, NY 10467 USA

[4] Montefiore Med Ctr, Dept Med, Div Hosp Med, Bronx, NY 10467 USA

[5] Montefiore Med Ctr, Dept Med, Div Crit Care Med, Bronx, NY 10467 USA

[6] Montefiore Med Ctr, Dept Med, Div Endocrinol, Bronx, NY 10467 USA

[7] Montefiore Med Ctr, Dept Med, Div Nephrol, Bronx, NY 10467 USA

来源：

JOURNAL OF HOSPITAL MEDICINE | 2020年 / 15卷 / 08期

关键词：

CORTICOSTEROID TREATMENT;

D O I：

10.12788/jhm.3497

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The efficacy of glucocorticoids in COVID-19 is unclear. This study was designed to determine whether systemic glucocorticoid treatment in COVID-19 patients is associated with reduced mortality or mechanical ventilation. This observational study included 1,806 hospitalized COVID-19 patients; 140 were treated with glucocorticoids within 48 hours of admission. Early use of glucocorticoids was not associated with mortality or mechanical ventilation. However, glucocorticoid treatment of patients with initial C-reactive protein (CRP) >= 20 mg/dL was associated with significantly reduced risk of mortality or mechanical ventilation (odds ratio, 0.23; 95% CI, 0.08-0.70), while glucocorticoid treatment of patients with CRP <10 mg/dL was associated with significantly increased risk of mortality or mechanical ventilation (OR, 2.64; 95% CI, 1.39-5.03). Whether glucocorticoid treatment is associated with changes in mortality or mechanical ventilation in patients with high or low CRP needs study in prospective, randomized clinical trials. (c) 2020 Society of Hospital Medicine

引用

页码：489 / 493

页数：5

共 14 条

[1]

[Anonymous], NAT I HLTH COVID 19

[2] Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial [J].

Arabi, Yaseen M. ;

Alothman, Adel ;

Balkhy, Hanan H. ;

Al-Dawood, Abdulaziz ;

AlJohani, Sameera ;

Al Harbi, Shmeylan ;

Kojan, Suleiman ;

Al Jeraisy, Majed ;

Deeb, Ahmad M. ;

Assiri, Abdullah M. ;

Al-Hameed, Fahad ;

AlSaedi, Asim ;

Mandourah, Yasser ;

Almekhlafi, Ghaleb A. ;

Sherbeeni, Nisreen Murad ;

Elzein, Fatehi Elnour ;

Memon, Javed ;

Taha, Yusri ;

Almotairi, Abdullah ;

Maghrabi, Khalid A. ;

Qushmaq, Ismael ;

Al Bshabshe, Ali ;

Kharaba, Ayman ;

Shalhoub, Sarah ;

Jose, Jesna ;

Fowler, Robert A. ;

Hayden, Frederick G. ;

Hussein, Mohamed A. .

TRIALS, 2018, 19

[3] Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China [J].

Cao, Jianlei ;

Tu, Wen-Jun ;

Cheng, Wenlin ;

Yu, Lei ;

Liu, Ya-Kun ;

Hu, Xiaoyong ;

Liu, Qiang .

CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :748-755

[4] Clinical and immunological features of severe and moderate coronavirus disease 2019 [J].

Chen, Guang ;

Wu, Di ;

Guo, Wei ;

Cao, Yong ;

Huang, Da ;

Wang, Hongwu ;

Wang, Tao ;

Zhang, Xiaoyun ;

Chen, Huilong ;

Yu, Haijing ;

Zhang, Xiaoping ;

Zhang, Minxia ;

Wu, Shiji ;

Song, Jianxin ;

Chen, Tao ;

Han, Meifang ;

Li, Shusheng ;

Luo, Xiaoping ;

Zhao, Jianping ;

Ning, Qin .

JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2620-2629

[5]

HORBY P, 2020, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA2021436

[6] Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients [J].

Lee, N ;

Chan, KCA ;

Hui, DS ;

Ng, EKO ;

Wu, A ;

Chiu, RWK ;

Wong, VWS ;

Chan, PKS ;

Wong, KT ;

Wong, E ;

Cockram, CS ;

Tam, JS ;

Sung, JJY ;

Lo, YD .

JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (04) :304-309

[7] Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza [J].

Lee, Nelson ;

Chan, Paul K. S. ;

Hui, David S. C. ;

Rainer, Timothy H. ;

Wong, Eric ;

Choi, Kin-Wing ;

Lui, Grace C. Y. ;

Wong, Bonnie C. K. ;

Wong, Rita Y. K. ;

Lam, Wai-Yip ;

Chu, Ida M. T. ;

Lai, Raymond W. M. ;

Cockram, Clive S. ;

Sung, Joseph J. Y. .

JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04) :492-500

[8] The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease [J].

McGonagle, Dennis ;

Sharif, Kassem ;

O'Regan, Anthony ;

Bridgewood, Charlie .

AUTOIMMUNITY REVIEWS, 2020, 19 (06)

[9] The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis [J].

Ni, Yue-Nan ;

Chen, Guo ;

Sun, Jiankui ;

Liang, Bin-Miao ;

Liang, Zong-An .

CRITICAL CARE, 2019, 23 (1)

[10] Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [J].

Richardson, Safiya ;

Hirsch, Jamie S. ;

Narasimhan, Mangala ;

Crawford, James M. ;

McGinn, Thomas ;

Davidson, Karina W. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20) :2052-2059

← 1 2 →